Dr. Mark Pollack, chief medical officer of Myriad Neuroscience, makers of the GeneSight test (IMAGE)

MediaSource

Dr. Mark Pollack, chief medical officer of Myriad Neuroscience, makers of the GeneSight test

Caption

Dr. Mark Pollack, chief medical officer at Myriad Neuroscience, says he and his team are working to help psychiatric care be as efficient as possible. The GeneSight test may reduce the trial and error process that is common when choosing a medication by providing information on how a patient may metabolize or respond based on their unique genetic profile.

Credit

Myriad Neuroscience, makers of the GeneSight test

Usage Restrictions

All multimedia is available for free and unrestricted media use with courtesy to Myriad Neuroscience, makers of the GeneSight test

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.